RPS6KA1 and acute myeloid leukemia: In summary, we found that activities of the PF-3758309 targeted kinases PAK1, RPS6KA1 and RPS6KA3 and the phosphorylation of PF-3758309 targeted sites were significantly correlated with the ex vivo response to the compound in primary AML cells.